Neuromodulators
From Proteopedia
(Difference between revisions)
| Line 56: | Line 56: | ||
*[[Treatments:AChE Inhibitor References]]<br /> | *[[Treatments:AChE Inhibitor References]]<br /> | ||
| + | =Adrenaline (Epinephrine)/Noradrenaline (Norepinephrine)= | ||
| + | *<scene name='82/829381/Cv/6'>Adrenaline (Epinephrine)</scene>. | ||
| + | *<scene name='82/829381/Cv/7'>Noradrenaline (Norepinephrine)</scene>. | ||
| + | *[[Phenylethanolamine N-methyltransferase]] (Noradrenaline N-Methyltransferase) catalyzes the conversion of norepinephrine (noradrenaline) to epinephrine (adrenaline). This is the last step in the conversion of tyrosine to adrenaline<ref>PMID:11591352</ref>. | ||
| + | ==[[Adrenergic receptor|Adrenergic receptors in general]]== | ||
| + | The [[Adrenergic receptor|adrenergic receptors]] are metabolic G protein-coupled receptors. They are the targets of catecholamines. The binding of an agonist to them causes a sympathetic response.<br /> | ||
| + | * The α-2 adrenergic receptor (A2AR) inhibits insulin or glucagons release.<br /> | ||
| + | * The β-1 adrenergic receptor (B1AR) increases cardiac output and secretion of rennin and ghrelin.<ref>PMID:23435379</ref><br /> | ||
| + | * The β-2 adrenergic receptor (B2AR) triggers many relaxation reactions. | ||
| + | ===β1 adrenergic receptor=== | ||
| + | |||
| + | *3D structures in [[Adrenergic receptor]]. | ||
| + | *[[UMass Chem 423 Student Projects 2011-1#Beta-1 Adrenergic GPCR|Beta-1 Adrenergic receptor]] | ||
| + | *G<sub>s</sub>: [[adenylate cyclase]] activated, cAMP up. | ||
| + | |||
| + | *β1-adrenergic agonists: | ||
| + | **Dobutamine, see [[UMass Chem 423 Student Projects 2011-1#Beta-1 Adrenergic GPCR|Beta-1 Adrenergic receptor]], [[2y00]], [[2y01]], [[6h7l]]. | ||
| + | **Isoprenaline, see [[UMass Chem 423 Student Projects 2011-1#Beta-1 Adrenergic GPCR|Beta-1 Adrenergic receptor]], [[2y03]]. | ||
| + | **Noradrenaline | ||
| + | **Carmoterol, see [[2y02]]. | ||
| + | **Salbutamol (Albuterol in USA), [[2y04]]. | ||
| + | *Beta blockers: | ||
| + | **Metoprolol | ||
| + | **Atenolol | ||
| + | **Bisoprolol | ||
| + | **Propranolol | ||
| + | **Timolol | ||
| + | **Nebivolol | ||
| + | **Vortioxetine | ||
| + | |||
| + | ===β2 adrenergic receptor=== | ||
| + | |||
| + | * The human β2 adrenergic receptor bound to a G-protein ([[3sn6]]) is featured in a scene above, and additional structures are on the [[Adrenergic receptor|Adrenergic receptor page]]. | ||
| + | *[[Beta-2 Adrenergic Receptor|Article Beta-2 Adrenergic Receptor by Wayne Decatur, David Canner, Dotan Shaniv, Joel L. Sussman, Michal Harel]] | ||
| + | *[[Beta-2 adrenergic receptor|Article Beta-2 adrenergic receptor by Joel L. Sussman, Tala Curry, Michal Harel, Jaime Prilusky]] | ||
| + | *[[Group:SMART:A Physical Model of the beta-Adrenergic Receptor]] | ||
| + | *G<sub>s</sub>: adenylate cyclase activated, cAMP up. For G<sub>s</sub> see [[Beta2 adrenergic receptor-Gs protein complex updated]]. | ||
| + | β2-adrenergic agonists: | ||
| + | **Salbutamol (Albuterol in USA) | ||
| + | **Bitolterol mesylate | ||
| + | **Formoterol | ||
| + | **Isoprenaline | ||
| + | **Levalbuterol | ||
| + | **Metaproterenol | ||
| + | **Salmeterol | ||
| + | **Terbutaline | ||
| + | **Ritodrine | ||
| + | *Beta blockers: | ||
| + | **Butoxamine | ||
| + | **Timolol | ||
| + | **Propranolol | ||
| + | **ICI-118,551 | ||
| + | **Paroxetine | ||
| + | |||
| + | ==[[Beta-adrenergic receptor kinase]]== | ||
| + | |||
| + | ==Monoamine oxidases (MAO)== | ||
| + | Monoamine oxidases (MAO) (EC 1.4.3.4) are a family of enzymes that catalyze the oxidation of monoamines including adrenaline, noradrenaline, serotonin and dopamine. | ||
| + | ===[[Monoamine oxidase]]=== | ||
| + | ===[[Monoamine oxidase b]]=== | ||
</StructureSection> | </StructureSection> | ||
== References == | == References == | ||
<references/> | <references/> | ||
Revision as of 12:05, 2 January 2022
| |||||||||||
References
- ↑ Martin JL, Begun J, McLeish MJ, Caine JM, Grunewald GL. Getting the adrenaline going: crystal structure of the adrenaline-synthesizing enzyme PNMT. Structure. 2001 Oct;9(10):977-85. PMID:11591352
- ↑ Huang J, Chen S, Zhang JJ, Huang XY. Crystal structure of oligomeric beta1-adrenergic G protein-coupled receptors in ligand-free basal state. Nat Struct Mol Biol. 2013 Apr;20(4):419-25. doi: 10.1038/nsmb.2504. Epub 2013 Feb, 24. PMID:23435379 doi:10.1038/nsmb.2504
